Nakamura et al., 1993 - Google Patents
Role of pseudorabies virus glycoprotein II in protection from lethal infectionNakamura et al., 1993
- Document ID
- 4221652166566802178
- Author
- Nakamura T
- Ihara T
- Nunoya T
- Kuwahara H
- Ishihama A
- Ueda S
- Publication year
- Publication venue
- Veterinary microbiology
External Links
Snippet
A monoclonal antibody (mAb), named 1.21, with complement-dependent neutralizing activity was produced against glycoprotein II (gII) of pseudorabies virus (PRV). By immunoaffinity chromatography using a mAB 1.21 column, gII was purified from Nonidet P40-lysates of PRV …
- 230000001665 lethal 0 title abstract description 8
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Libeau et al. | A competitive ELISA using anti-N monoclonal antibodies for specific detection of rinderpest antibodies in cattle and small ruminants | |
Dreesen et al. | Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization | |
MOSLEY et al. | Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis | |
Glorioso et al. | Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity | |
Johnson et al. | Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus | |
Lin et al. | Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus | |
Stanley et al. | Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice | |
Smiley et al. | Herpes simplex virus type 1 infection of endothelial, epithelial, and fibroblast cells induces a receptor for C3b. | |
Wathen et al. | Production and characterization of monoclonal antibodies directed against pseudorabies virus | |
Mester et al. | Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies | |
EP0402029B1 (en) | Monoclonal antibodies for post exposure treatment of rabies | |
Pedersen Jr et al. | Separation, isolation, and immunological studies of the structural proteins of Venezuelan equine encephalomyelitis virus | |
Schulman | The role of antineuraminida se antibody in immunity to influenza virus infection | |
Nakamura et al. | Role of pseudorabies virus glycoprotein II in protection from lethal infection | |
Melnick et al. | Studies on herpes simplex virus and cancer | |
Shimizu et al. | Monoclonal antibodies with neutralizing activity to equine herpesvirus 1 | |
Israel et al. | Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines | |
Smith et al. | Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2 | |
Butchko et al. | Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses | |
KR100341958B1 (en) | Vaccine Composition | |
Mukamoto et al. | Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine | |
JPS59144720A (en) | False hydrophobic vaccine | |
Marshall et al. | Passively administered neutralizing monoclonal antibodies do not protect calves against bovine herpesvirus 1 infection | |
Yohn et al. | EGHO-4 Viruses: Improved Methods and Strain Selection for Identification and Serodiagnosis | |
Bernstein et al. | Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence |